H.R. 209 — Introduced in House

I 114th CONGRESS 1st Session H. R. 209 IN THE HOUSE OF REPRESENTATIVES January 8, 2015 Mr. Doggett (for himself, Mr. McGovern, and Mr. Marino) introduced the following bill; which was referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To permanently allow an exclusion under the Supplemental Security Income program and the Medicaid program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions. 1. Short title This Act may be cited as the Ensuring Access to Clinical Trials Act of 2015. 2. Elimination of sunset provision Effective as if included in the enactment of the Improving Access to Clinical Trials Act of 2009 (Public Law 111–255, 124 Stat. 2640), section 3 of that Act is amended by striking subsection (e).